What is the appropriate dose of MiraLAX (polyethylene glycol) for a 9-month-old infant with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MiraLAX Dosing for a 9-Month-Old Infant with Constipation

For a 9-month-old infant with constipation, polyethylene glycol 3350 (MiraLAX) should be dosed at 0.8-1 g/kg/day, which typically translates to approximately 7-9 grams daily for an average-sized 9-month-old, dissolved in 2-4 ounces of any beverage. 1

Age-Appropriate First-Line Therapy

  • Polyethylene glycol (PEG) 3350 is the laxative of first choice for infants 6 months and older according to the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition 1
  • For infants under 6 months, lactulose or lactitol-based medications are the recommended alternatives 2
  • At 9 months of age, this infant falls squarely within the appropriate age range for PEG 3350 therapy 1, 3

Specific Dosing Instructions

Initial dosing:

  • Start with 0.8-1 g/kg/day as a single daily dose 1
  • For a typical 9-month-old weighing 8-9 kg, this equals approximately 7-9 grams daily 1
  • Dissolve the powder completely in 2-4 ounces of any beverage (breast milk, formula, water, or juice) 1, 4

Titration strategy:

  • The goal is to produce 2-3 soft, painless stools daily 1
  • Adjust the dose based on stool frequency and consistency 1
  • PEG is highly effective with dose-dependent efficacy 5

Important Clinical Considerations

Before initiating therapy:

  • Rule out fecal impaction through digital rectal examination if the infant appears to have significant stool burden 1, 6
  • If impaction is present, consider a glycerin suppository (pediatric formulation) first for mechanical disimpaction before starting maintenance PEG therapy 1, 6

Maintenance therapy duration:

  • Treatment typically needs to continue for many months before the child regains normal bowel motility and rectal perception 1
  • Premature discontinuation is a common pitfall—parents often cease treatment too soon 1

Adjunctive Non-Pharmacological Measures

  • Increase fluid intake to maintain proper hydration 1
  • Offer fruit juices containing sorbitol (prune, pear, apple) which can help increase stool frequency 1
  • If the infant is eating solid foods, emphasize high-fiber options like fruits, vegetables, and whole grains 1

Safety Profile

  • PEG 3350 has an excellent safety profile with only minor adverse events reported 5
  • Common side effects include bloating, abdominal discomfort, and flatulence 4
  • Ensure adequate fluid intake throughout the day 4
  • In patients predisposed to water and electrolyte imbalances, monitoring of serum electrolytes should be considered 5

Common Pitfalls to Avoid

  • Do not rely solely on dietary changes if impaction is present, as this can worsen constipation 1
  • Do not use stimulant laxatives (bisacodyl, senna) as first-line therapy in infants—these are not appropriate for this age group and safer alternatives exist 1
  • Do not discontinue therapy prematurely—maintenance may need to continue for months 1
  • Ensure the powder is fully dissolved before administration—do not give if clumps remain 7

FDA Labeling Note

The FDA-approved labeling for over-the-counter PEG 3350 states "children 16 years of age or under: ask a doctor," which means this requires physician prescription and supervision for a 9-month-old 7. However, extensive clinical evidence and pediatric gastroenterology guidelines strongly support its use in this age group under medical guidance 1, 2, 3, 5.

References

Guideline

Treatment of Constipation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Constipation in infants and children: How should it be treated?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016

Guideline

Polyethylene Glycol 3350 Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Role of Polyethylene Glycol in the Treatment of Functional Constipation in Children.

Journal of pediatric gastroenterology and nutrition, 2017

Guideline

Lactulose Therapy for Disimpaction in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.